RecruitingNCT07516886

Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy

Sponsor

Lithuanian University of Health Sciences

Enrollment

500 participants

Start Date

Jan 22, 2024

Study Type

OBSERVATIONAL

Conditions

Prostate Cancer (Adenocarcinoma)Radical Prostatectomy Prostate Cancer (Post Prostatectomy)Prostate Cancer (Diagnosis)Prostate Specific Antigen

Summary

This prospective observational study aims to evaluate the prognostic significance of early postoperative prostate-specific antigen (PSA) levels in patients undergoing radical prostatectomy for prostate cancer. No investigational interventions will be performed. All diagnostic procedures, follow-up assessments, and treatments will be conducted in accordance with standard clinical practice and established prostate cancer management guidelines. Participation in the study will not influence treatment decisions.

Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Radical Prostatectomy for people with prostate cancer (adenocarcinoma), prostate cancer (diagnosis), and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURERadical Prostatectomy

Radical prostatectomy for the treatment of prostate cancer. Open retropubic, laparoscopic or robot-assisted.

Locations(1)

Lithuanian University of Health Sciences Hospital Kaunas Clinics, Department of Urology

Kaunas, Kauno, Lithuania

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07516886

Related Trials

Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy

NCT077113141 location

REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)

NCT073024511 location

PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer

NCT074260551 location

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

NCT06592924395 locations

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

NCT068443837 locations